Tolerability of high dose carbamazepine monotherapy in treatment of epilepsy;Verträglichkeit einer hochdosierten carbamazepin-monotherapie zur epilepsiebehandlung

Nervenarzt

Volumn 73, Issue 6, 2002, Pages 533-537

  Bauer, J ^a   Hermann, A ^a   Reuber, M ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Carbamazepine; Epilepsy; Monotherapy; Tolerability

Indexed keywords

CARBAMAZEPINE; ELECTROLYTE;

ANTICONVULSANT THERAPY; ARTICLE; BLOOD CELL COUNT; CLINICAL EXAMINATION; DRUG MEGADOSE; DRUG TOLERABILITY; EPILEPSY; FUNCTIONAL ASSESSMENT; HUMAN; LABORATORY DIAGNOSIS; LIVER FUNCTION TEST; MEASUREMENT; MONOTHERAPY; SIDE EFFECT;

ADOLESCENT; ADULT; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; EPILEPSIES, PARTIAL; EPILEPSY, GENERALIZED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0036933754     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-002-1310-7     Document Type: Article

References (36)

1. Bauer J (1996) Seizure-inducing effects of antiepileptic drugs: a review. Acta Neurol Scand 94: 367-377
2. Bernus I, Dickinson RG, Hooper WD, Eadie MJ (1996) Dose-dependent metabolism of carbamazepine in humans. Epilepsy Res 24: 163-72
3. Bertilsson L, Rane A (1980) Methods for the determination of Carbamazepine and its epoxide metabolite. In: Johannessen SI (ed) Antiepileptic Therapy: advances in drug monitoring. Raven Press, New York, pp 325-332
4. Callaghan N, O'Callaghan M, Duggan B, Feely M (1978) Carbamazepine as a single drug in the treatment of epilepsy. A prospective study of serum levels and seizure control. J Neurol Neurosurg Psychiatry 41: 907-12
5. Callaghan N, Kenny RA, O'Neill B, Crowley M, Goggin T (1985) A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy. J Neurol Neurosurg Psychiatry 48: 639-644
6. Delgado-Escueta AV, Treiman DM, Walsh GO (1983) The treatable epilepsies (second of two parts). N Engl J Med 308: 1576-1584
7. Eadie MJ (1994) Plasma antiepileptic drug monitoring in a neurological practice: a 25-year experience. Ther Drug Monit 16: 458-68
8. Faigle JW, Feldmann KF, Baltzer V (1977) Anticonvulsant effect of Carbamazepine. An attempt to distinguish between the potency of the parent drug and its epoxide metabolite. In: Gardner-Thorpe C, Meinardi H, Pippenger CE (eds) Antiepileptic Drug Monitoring. Pitman Med Publ, London, pp 104-109
9. Fisher RS, Cysyk B (1988) A fatal overdose of Carbamazepine case report and review of literature. Clin Toxicol 26: 477-486
10. Fröscher W (1987) Epilepsie-Therapie bei Erwachsenen: Trends, Stellenwert des Carbamazepins. In: Krämer G, Hopf HC (eds) Carbamazepin in der Neurologie. Thieme, Stuttgart New York, pp 170-182
11. Fröscher W, Eichelbaum M, Hildenbrand G, Hildenbrand K, Penin (1982) Prospektive Studien zu Epilepsiebehandlung mit Carbamazepin. Fortschr Neurol Psychiat 50: 396-408
12. Jürgens U, May T, Hillenkötter K, Rambeck B (1984) Systematic comparison of three basic methods of sample pretreatment for high-performance liquid; chromatographic analysis of antiepileptic drugs using gas chromatography as a reference method. Ther Drug Monit 6: 334-343
13. Kälviäninen R, Aikia M, Saukkonnen AM, Mervaala E, Riekkinnen PJ (1995) Vigabatrin vs Carbamazepine monotherapy in patients with newly diagnosed epilepsy. Arch Neurol 52: 989-996
14. Krämer G (1987) Zur Plasmakonzentration von Carbamazepin:"Therapeutischer Bereich" und Nutzen der Bestimmung. In: Krämer G, Hopf HC (eds) Carbamazepin in der Neurologie. Thieme, Stuttgart New York, pp 44-59
15. Krämer G (1989) Stellenwert der Plasma-spiegelbestimmung von Antiepileptika. Fortschr Neurol Psychiat 57: 411-424
16. Kutt H, Penry JK (1974) Usefulness of blood levels of antiepileptic drugs. Arch Neurol 31: 283-288
17. Lanchote VL, Bonato PS, Campos GM, Rodrigues I (1995) Factors influencing plasma concentrations of Carbamazepine and Carbamazepine-10,11-epoxide in epileptic children and adults. Ther Drug Monit 17: 47-52
18. Lesser RP, Pippenger CE, Lüders H, Dinner DS (1984) High-dose monotherapy in treatment of intractable seizures. Neurology 34: 707-711
19. Marson AG, Williamson PR, Hutton JL, Clough HE, Chadwick, DW (2000) Carbamazepine versus Valproate monotherapy for epilepsy (Cochrane Review). In: The Cochrane Library. Update Software, Oxford, issue 4
20. Mattson RH, Cramer JA, Collins JF and the Department of Veterans Affairs Epilepsy Cooperative Studies No. 264 Group (1992) A Comparison of Valproate with Carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. N Engl J Med 327: 765-771
21. Mattson RH, Cramer JA, Collins JF and the Department of Veterans Affairs Epilepsy Cooperative Studies No. 118 and No. 264 Group (1996) Prognosis for total control of complex partial and secondarily generalized tonic clonic seizures. Neurology 47: 68-76
22. Mikati M (1991) The Newer Antiepileptic Drugs: Carbamazepine and Valproic acid. Pediat Ann 20: 34-40
23. Monaco F, Riccio A, Benna P et al. (1976) Further observations on carbamazepine plasma levels in epileptic patients. Relationships with therapeutic and side effects. Neurology 26: 936-73
24. Patsalos PN, Stephenson TJ, Krishna S, Elyas AA, Lascelles PT, Wiles CM (1985) Side effects induced by Carbamazepine-10,11-epoxide. Lancet 311: 496
25. Rambeck B, Sälke-Treumann A, May T, Boenigk HE (1990) Valproic acid-induced Carbamazepine-10,11-epoxide toxicity in children and adolescents. Eur Neurol 30: 79-83
26. Reynolds EH, Shorvon SD (1981) Monotherapy or polytherapy for epilepsy? Epilepsia 22: 1-10
27. Reynolds EH (1987) Polytherapy, monotherapy, and Carbamazepine. Epilepsia 28: 77-80
28. Sander JWAS (1993) Some aspects of prognosis in the epilepsies: a review. Epilepsia 34: 1007-1016
29. Schmidt D (1983) Reduction of two-drug therapy in intractable epilepsy. Epilepsia 24: 368-376
30. Schoeman JF, Elyas AA, Brett EM, Lascelles PT (1984) Altered ratio of Carbamazepine-10, 11-epoxide/Carbamazepine in plasma of children: evidence of anticonvulsant drug interaction. Dev Med Child Neurol 26: 749-755
31. Schoeman JF, Elyas AA, Brett EM, Lascelles PT (1984) Correlation between plasma Carbamazepine-10,11-epoxide concentration and drug side-effects in children with epilepsy. Dev Med Child Neurol 26: 756-764
32. Semah F, Gimenez F, Longer E, Laplane D, Thuillier A, Baulac M (1994) Carbamazepine and its epoxide: an open study of efficacy and side effects after Carbamazepine dose increment in refractory partial epilepsy. Ther Drug Monit 16: 537-540
33. Strandjord RE, Johannessen SI (1980) Single drug therapy with Carbamazepine in patients with epilepsy: serum levels and clinical effect. Epilepsia 21: 652-655
34. Tomson T, Almkvist O, Nilsson BY, Svensson JO, Bertilsson L (1990) Carbamazepine 10, 11-epoxide in epilepsy: a pilot study. Arch Neurol 47: 888-892
35. Troupin A, Ojemann LM, Halpern L, Dodrill C, Wilkus R, Friel P, Feigl P (1977) Carbamazepine. A double-blind comparison with phenytoin. Neurology 27: 511-519
36. Weaver DF, Camfield P, Fraser A (1988) Massive carbamazepine overdose: Clinical and pharmacologic observations in five episodes. Neurology 38: 755-759